¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"human scarlet fever immune serum"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
¿µ¹® fever blister ÇÑ±Û ¿­¼º¼öÆ÷
¼³¸í   
  1Çü ´Ü¼ø Ç츣Æä½º ¹ÙÀÌ·¯½º(herpes simplex virus)ÀÇ °¨¿°¿¡ ÀÇÇØ¼­ »ý±â´Â ÇǺκ´À¸·Î ÁÖ·ÎÀÔ¼ú¿¡ º´º¯À» °¡Áö´Â º´À» ¸»ÇÑ´Ù. ÀÔ¼úÆ÷Áø(herpes labialis)¿Í µ¿ÀǾî·Î ¾²ÀδÙ. ÁܼøÆ÷ÁøÁß ÀÔÁÖÀ§¿¡ »ý±â´Â °ÍÀ» ÁöÁ¤Çϴ ¸»ÀÌ´Ù.
  
  ´Ü¼øÇ츣Æä½º(herpes simplex)¶õ º¸Åë ÀÛÀº ¹°ÁýÀÌ ¿©·¯ °³ ¸ð¿© »ý±â´Â ÇǺκ´À» ¸»ÇÑ´Ù. Àß ¹ß»ýÇϴ °÷Àº ÀÔ¼ú, ¿ÜÀ½ºÎ µîÀ̸ç ÁַΠÇǺο͠Á¡¸·ÀÇ ÀÌÇàºÎ¿¡ ³ªÅ¸³­´Ù. ¹°ÁýÀº ½Ò¾Ë¸¸ÇÑ Å©±âÀÇ ÀÛÀº ¹°Áý ¶Ç´Â °í¸§À» Æ÷ÇÔÇϴ ¹°ÁýÀ¸·Î ¸î °³°¡ ¹«¸®¸¦ Áö¾î ³ªÅ¸³ª´Âµ¥, ¸çÄ¥ Áö³ª¸é ¹°ÁýÀÇ ¸·ÀÌ ÅÍÁö°í, ÇǺÎÀǠǥ¸éÀÌ Áø¹«¸£°í Çæ¾î¼­ ÀÛÀº »ó󸦠Çü¼ºÇÏ¿© ³ëÃâµÈ´Ù. ±×¸®°í µüÁö°¡ ¾É¾Æ ±»¾îÁø ´ÙÀ½ 7~10ÀÏ °¡·® Áö³ª¸é ÀúÀý·Î ³´´Â´Ù. ´Ü¼ø¼º Æ÷ÁøÀº ¹ß»ý ºÎÀ§¿¡ µû¶ó¼­ ÀÔ¼úÆ÷Áø°ú À½ºÎÆ÷ÁøÀ¸·Î ±¸ºÐµÈ´Ù. ÀÔ¼úÆ÷ÁøÀº ÇÇ·ÎÇϰųª °ñÇÁÀå ¶Ç´Â ÇØ¼ö¿åÀå µîÁö¿¡¼­ ÇÞºµ¿¡ ½ÉÇϰԠ³ëÃâµÈ ÈÄ¿¡ À¯¹ßµÇ´Â °æ¿ì°¡ ¸¹´Ù. À½ºÎÆ÷ÁøÀº ¼º±³¿¡ ÀÇÇÏ¿© Àü¿°µÇ´Â °æ¿ìµµ ÀÖÀ¸¸ç, ÁßÁõÀÏ ´ë¿¡´Â °Ý½ÉÇÑ ¾ÆÇÄÀ» ¼ö¹ÝÇϸç ÁÖÀ§ÀÇ ¸²ÇÁÀýÀÇ Á¾´ë¸¦ ÃÊ·¡Çϱ⵵ ÇÑ´Ù. Á÷¾÷»ó Á¢ÃË ±âȸ°¡ ¸¹Àº Àǻ糪 °£È£»çÀÇ °æ¿ì´Â ¼Õ°¡¶ô ³¡¿¡ ¹ß»ýÇÒ ¶§µµ ÀÖ´Ù. À¯¾ÆÀÇ °æ¿ì¿¡´Â °í¿­°ú ÀεÎÅë µîÀÇ ½ÉÇÑ Áõ¼¼°¡ ³ªÅ¸³ª±âµµ ÇÏ¿© ¶§·Î´Â ¸ñ¼û±îÁö ÀҴ´Ù.
  
  
¿µ¹® epidemic hemorrhagic fever ÇÑ±Û À¯ÇàÃâÇ÷¿­
¼³¸í   
  Çѱ¹ÀüÀï´ç½Ã ±¹³»¿¡¼­ ¹ß°ßµÇ¸é¼­ ÇѶ§ Çѱ¹Çü ÃâÇ÷¿­(Korean hemorrhagic fever)À̶ó°íµµ ºÒ¸®¿ü´ø ÀÌ º´Àº °©Àڱ⠽ÃÀÛÇϴ ¿ÀÇÑ, µÎÅë, ±ÙÀ°ÅëÀ» ³ªÅ¸³»°í À̾ 3~5ÀÏ ³»¿¡ Àü½Å ÇǺΠ¹× °ø¸·ÃâÇ÷, Ç÷¼ÒÆÇ°¨¼ÒÁõ, ´Ü¹é´¢ ¹× ½ÅÀå ±â´É»ó½Ç µîÀÌ ¿Â´Ù. ¸»±â¿¡´Â ¼îÅ© ¹× Àúü¿ÂÀÌ µÉ ¼ö ÀÖ´Ù. Ã³À½ 7~10ÀÏ °£¿¡ »ì¾Æ³²Àº È¯ÀÚµéÀº ¼­¼­È÷ È¸º¹µÇ³ª ´Ü¹é´¢ÀÇ ÇÌ´¢´Â ¼ö ÁÖ°£ Áö¼ÓµÈ´Ù. Áõ¼¼¿¡ µû¶ó¼­ ¹ß¿­±â, ÀúÇ÷¾Ð±â, °¨´¢±â, ÀÌ´¢±â, È¸º¹±â·Î ºñ±³Àû Æ¯ÀÌÇϰԠ±¸ºÐµÈ´Ù. Hantaan virus¶ó°í ºÒ¸®´Â ÀÌ º´¿øÃ¼´Â ¼¼Æ÷Áú¿¡¼­ ÀÚ¶ó´Â RNA ¹ÙÀÌ·¯½ºÀ̸ç Bunyaviridae°ú¿¡ ¼ÓÇϴ Hanta ¹ÙÀÌ·¯½º¼Ó¿¡ ¼ÓÇϴ Á¾(species)À¸·Î ÇÑź ¹ÙÀÌ·¯½º À̿ܿ¡ Puumula virus, Hill virus°¡ ÀÖ´Ù. ÃÖ±Ù¿¡ È¯ÀڷκÎÅÍ ÇÑź¹ÙÀÌ·¯½º¿Í´Â ±¸ºÐµÇ´Â Seoul virus°¡ ºÐ¸®, µ¿Á¤µÊ¿¡ µû¶ó¼­ ¾ß¿ÜÇü(Hantaan virus)°ú µµ½ÃÇü(Seoul virus)ÀÌ º´¿øÃ¼°¡ ¼­·Î ´Ù¸£´Ù´Â Á¡ÀÌ ¾Ë·ÁÁ³´Ù. Çѱ¹À» ºñ·ÔÇÏ¿© ¸¸ÁÖ, ½Ãº£¸®¾Æ µîÁö¿¡¼­ À¯ÇàÇϴ ÁúȯÀ¸·Î ¾Ë·ÁÁ³À¸³ª ÇÑź¹ÙÀÌ·¯½ºÀÇ ¹ß°ßÀ» °è±â·Î Ç÷û°Ë»ç°¡ °¡´ÉÇØÁöÀÚ ÇÑź¹ÙÀÌ·¯½º ³»Áö´Â À̿͠Ç׿ø±¸Á¶°¡ À¯»çÇÑ ¹ÙÀÌ·¯½º·Î »ý±â´Â °¨¿°ÁõÀÌ ¼¼°è °¢Ã³¿¡ ºÐÆ÷µÇ¾î Àִٴ °ÍÀÌ ÆÇ¸íµÇ¾ú´Ù. °èÀýÀûÀΠ¹ß»ýÀº Æ¯ÀÌÇϸç, ±¹³»¿¡¼­´Â º½°ú °¡À»¿¡ µÎ ¹øÀÇ À¯ÇàÀÌ ÀÖ´Ù°í ÇÏÁö¸¸ ÃÖ±Ù¿¡´Â °¡À»ÀÇ À¯ÇàÀÌ Å©´Ù. Æ¯Â¡ÀûÀΠÀ°¾ÈÀû ¼Ò°ßÀº ÄáÆÏ¼ÓÁúÀÇ ÃâÇ÷, ¿À¸¥½É¹æÃâÇ÷, ³úÇϼöü Àü¿±ÀÇ ±«»çÀ̸ç, À̹ۿ¡ Èĺ¹°­ ¿¬Á¶Á÷ÀÇ ½ÉÇÑ ºÎÁ¾, Ã¼°­³»·Î ´©ÃâµÈ Ã¼¾× Àú·ù, À帷ÀÇ »êÀ缺 ÃâÇ÷, µ¹Ã¢ÀÚÀÇ Á¡¸·ÃâÇ÷, ÆóºÎÁ¾ ³»Áö´Â ÆóÃâÇ÷ µîÀÌ´Ù. Á¶Á÷¼Ò°ßÀǠƯ¡Àº ¿©·¯ Àå±âÀÇ ÃâÇ÷°ú ÄáÆÏ¼ÓÁú, ³úÇϼöü, ºÎ½Å µî¿¡ »ý±â´Â ÃÊÁ¡¼º ÀÀ°í¼º ±«»ç¿Í °¢ Àå±âÀÇ ±¤¹ü¼º ´ÜÇÙ¼¼Æ÷ Ä§À±À̸ç, ¼¼Á¤¸ÆÀÌ È®ÀåµÇ°í ¿ïÇ÷ÀÌ »ý±â°í Ç÷Àå°ú ÀûÇ÷±¸°¡ Ç÷°ü¿Ü·Î ´©ÃâµÇ°í ºÎÀ§¿¡ µû¶ó¼­´Â ÃÊÁ¡¼º ¸ð¼¼Ç÷°ü ÆÄ¿­ÀÌ ³ªÅ¸³ª ÀÖ´Ù.
¿µ¹® relapsing fever ÇÑ±Û Àç±Í¿­
¼³¸í   
  Borrelia ¼ÓÀÇ ½ºÇÇ·ÎÇ쟠°¨¿°¿¡ ÀÇÇØ¼­ »ý±ä´Ù. ÀÌ Áøµå±â¿¡ ÀÇÇØ ¸Å°³µÇ°í ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾Æ, ¹Ì±¹, À¯·´ µî, ¼¼°è °¢Áö¿¡¼­ º¼ ¼ö ÀÖ´Ù. Àẹ±â´Â 3~10ÀÏ¿¡ ¿ÀÇÑ, ÀüÀ², µÎÅë, ±¸¿ª µîÀ» ¼ö¹ÝÇϴ ¹ß¿­·Î ¹ß»ýÇÑ´Ù. ¹ß¿­Àº Á¾Á¾ 40¡É À̻󿡠´ÞÇϰí 4~5ÀÏ¿¡ ÀÚ¿¬È÷ ÇØ¿­µÈ´Ù. ¾à 1ÁÖÀÏÀÇ ¹«¿­±â µÚ, ´Ù½Ã ¶È°°Àº Áõ»óÀ» µÇÇ®ÀÌÇÑ´Ù. À̿͠°°Àº ¹ßÀÛÀ» ¼­³Ê ¹ø µÇÇ®ÀÌÇÑ´Ù. Ç÷¾×À¸·ÎºÎÅÍÀÇ Borrelia °ËÃâ·Î Áø´ÜÀÌ È®Á¤µÈ´Ù. Åë»ó Ç÷¾×µµ¸» Ç¥º»À» °¨ÀÚ¿°»öÇØ¼­ °ËÃâÇÑ´Ù. Ä¡·á¿¡´Â Æä´Ï½Ç¸°, Åׯ®¶ó»çÀÌŬ¸°, Å¬·Î¶÷Æä´ÏÄÝÀÌ È¿°úÀûÀÌ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • human T-cell lymphoma/leukemic virus
    »ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T-cell lymphotropic virus
    »ç¶÷T¼¼Æ÷¸²ÇÁģȭ¹ÙÀÌ·¯½º
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
  • antilymphocytic serum
    Ç׸²ÇÁ±¸Ç÷û
  • antiplatelet serum
    Ç×Ç÷¼ÒÆÇÇ÷û
  • antirabies serum
    Ç×±¤°ßº´Ç÷û
  • antitetanic serum
    ÇׯĻódzÇ÷û
  • antithymocyte serum
    Ç×°¡½¿»ù¼¼Æ÷Ç÷û, Ç×Èä¼±¼¼Æ÷Ç÷û
  • antitoxic serum
    Ç×µ¶¼ÒÇ÷û
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • allergenic serum
    ¾Ë·¹¸£±âÇ÷û
  • bovine serum albumin
    ¼ÒÇ÷û¾ËºÎ¹Î
  • convalescent serum
    ȸº¹±âÇ÷û
  • fetal bovine serum
    ¼ÒžÆÇ÷û
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bovine serum albumin
    ¼ÒÇ÷û¾ËºÎ¹Î
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
  • serum accident
    Ç÷ûºÎÀÛ¿ë
  • serum amylase
    Ç÷û¾Æ¹Ð¶ó¾ÆÁ¦
  • convalescent serum
    ȸº¹±âÇ÷û
  • fetal bovine serum
    ¼ÒžÆÇ÷û
  • foreign serum
    ÀÌÁ¾Ç÷û
  • hyperimmune serum
    °í¸é¿ªÇ÷û
  • serum hepatitis
    Ç÷û°£¿°
  • icteric serum
    Ȳ´ÞÇ÷û
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û
  • inactive serum
    ºñȰ¼ºÇ÷û
  • serum imbibition
    Ç÷ûÈí¼ö
  • serum intoxication
    Ç÷ûÁßµ¶
  • lactescent serum
    À¯È­Ç÷û
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hCG (Human chorionic gonadotropin)
    ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
  • human Herpesvirus 6 (HHV-6)
    Á¦6Çü »ç¶÷ Ç츣Æä½º¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T lymphotrophic virus (HTLV)
    »ç¶÷ T ¸²ÇÁ±¸ ģȭ¼º ¹ÙÀÌ·¯½º
  • human T lymphotropic virus
    »ç¶÷<ÀÎ
  • human T-cell lymphotrophic virus
    Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
  • human acariasis
    ÀÎü³»Áøµå±âÁõ, ÀÎü³»°³¼±Ã溴(ìÑô÷Ò®ËÊàÈõùÜ»).
  • human bite
    »ç¶÷±³»ó(¡­Îáß¿).
  • human bite
    »ç¶÷±³»ó(¡­±³»ó).
  • human calicivirus
    »ç¶÷ ͏®½Ã¹ÙÀÌ·¯½º
  • human chorionic gonadotropin =HCG
    »ç¶÷À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human chorionic gonadotropin =HCG
    »ç¶÷ À¶¸ð¼º(ëÖÙ¾àõ) ¼º¼±ÀÚ±ØÈ£¸£¸ó.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fever,q fever
    Q ¿­
  • fort bragg fever => pretibial fever
  • antigen, human leukocyte (HLA)
    »ç¶÷ ¹éÇ÷±¸Ç׿ø, HLAÇ׿ø
  • citrated normal human plasma
    Á¤»óÀα¸¿¬»ê¿°Ã·°¡Ç÷Àå.
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • ecology, human
    Àΰ£»ýÅÂÇÐ.
  • hCG (Human chorionic gonadotropin)
    ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
  • hiv(human immunodeficiency virus)
    ÀÎü¸é¿ª°áÇ̹ÙÀÌ·¯½º(ìÑô÷Øóæ¹ÌÀù¹¡­)
  • human Herpesvirus 6 (HHV-6)
    Á¦6Çü »ç¶÷ Ç츣Æä½º¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T lymphotrophic virus (HTLV)
    »ç¶÷ T ¸²ÇÁ±¸ ģȭ¼º ¹ÙÀÌ·¯½º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immune globulin
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • immune lysis
    ¸é¿ª ¿ëÇØ(Øóæ¹éÁú°)
  • immune opsonin
    ¸é¿ª(Øóæ¹) ¿É¼Ò´Ñ
  • immune reaction
    ¸é¿ª ¹ÝÀÀ(Øóæ¹Úãëë)
  • immune response
    ¸é¿ª ´ëÀÀ(Øóæ¹Óßëë)
  • immune response gene
    ¸é¿ª ´ëÀÀ À¯ÀüÀÚ(Øóæ¹Óßëëë¶îîí­)
  • immune surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • simian acquired immune deficiency syndrome
    ¿ø¼þÀÌ ÈÄõ¼º¸é¿ª°áÇÌÁúȯ(ý­ô¸àõØóæ¹ÌÀù¹òðü´)
  • specific immune suppression
    ƯÀÌ ¸é¿ª¾ï¾Ð(÷åì¶Øóæ¹åääâ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NHS Nance-Horan syndrome; National Health Service; National Hospice Study; normal horse serum; normal hu...
HCS Hajdu-Cheney syndrome; Hazard Communication Standard; health care support; hourglass contraction of ...
HHS [Department of] Health and Human Services; Hearing Handicap Scale; hereditary hemolytic syndrome; hu...
HPL human parotid lysozyme; human peripheral lymphocyte; human placental lactogen
ISG Immune Serum Globulin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PNHS pooled normal human serum
ARF Acute Rheumatic Fever
ASF African Swine Fever
ASFV African Swine Fever Virus
AHF Argentine Haemorrhagic Fever
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • human counter
    Àü½Å °è¼ö ÀåÄ¡
    µ¿ÀǾî=whole body counter.
  • human ecology
    Àΰ£ »ýÅÂÇÐ, Àηù »ýÅÂÇÐ
    Àΰ£°ú ȯ°æ°úÀÇ »óÈ£ ÀÛ¿ëÀ» ¿¬±¸ÇÏ´Â »ý¹°ÇÐÀÇ ÇÑ ºÐ¾ß.
  • human fetal membrane
    »ç¶÷ ÅÂ¾Æ ¸·
  • human genome
    Àΰ£ °Ô³ð
  • human growth hormone
    ¼ºÀå È£¸£¸ó
    ¼ºÀåÀ» ÃËÁøÇÏ´Â ¹°ÁúÀ» ÃÑĪÇϸç, ƯÈ÷ ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÀ» ¸»ÇÑ´Ù.
  • human histocompatibility antigen
    ÀÎü Á¶Á÷ ÀûÇÕ Ç׿ø
  • human immunodeficiency virus
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º
  • human immunodeficiency virus infection
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º °¨¿°
  • human leukocyte antigen-B27
    ÀÎü ¹éÇ÷±¸ Ç×ü-B27
    º¸Åë °­Á÷¼º ôÃß¿° ȯÀÚ¿¡¼­ ³ªÅ¸³ª´Â À¯Àü Ç¥½ÃÀÚ.
  • human menopausal gonadotropin
    Æä°æ ¿©¼º ¼º¼± ÀÚ±Ø È£¸£¸ó
  • human oncovirus
    »ç¶÷ ¾Ï ¹ÙÀÌ·¯½º
  • human papilloma virus
    ÀÎü À¯µÎÁ¾ ¹ÙÀÌ·¯½º
    ÀÎü Áúȯ°ú µ¿¹° Áúȯ°úÀÇ À¯»çÁ¡Àº ¸Å¿ì ³î¶ø´Ù. ÇǺÎÀÇ ÆíÆò »óÇÇ ¼¼Æ÷¿¡ ´ëÇÑ ÇöÀúÇÑ Ä£È­¼ºÀ» º¸ÀδÙ. µ¿¹°¿¡¼­ À¯µÎÁ¾ ¹ÙÀÌ·¯½º´Â ÆíÆò »óÇÇ¿¡ ¾ç¼º À¯µÎÁ¾, ÀåÀÇ ¼± »óÇÇ¿¡ ¼±Á¾, ¹æ±¤¿¡ À¯µÎÁ¾À» ÀÏÀ¸Å°¸ç »ó´çÇÑ ¼ö°¡ ¾Ç¼ºÀ¸·Î ÁøÇàµÈ´Ù. »ç¶÷¿¡¼­µµ ÈĵÎÀÇ À¯µÎÁ¾, ¿ÜÀ½, À½°æ, Ç×¹® ÁÖº¯ºÎ¿¡ ÷±Ô Äܵô·Ò
  • human parvovirus-like agent
    »ç¶÷ ÆÄº¸ ¹ÙÀÌ·¯½º À¯»çü
  • human pituitary gonadotropin
    ³úÇϼöü¼º ¼º¼± ÀÚ±Ø È£¸£¸ó
  • human placental lactogen
    »ç¶÷ ÅÂ¹Ý À¯¼± ÀÚ±Ø È£¸£¸ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
humoral immune response <immunology> Those immune responses mediated by antibody.
(06 Mar 1998)
specific immune globulin Globulin fraction of pooled serums (or plasma) selected for high titre of antibodies specific for a particular antigen, or from persons specifically immunised.
(05 Mar 2000)
immune <immunology> Protected against, infectious disease by either specific or non-specific mechanisms.
Origin: L. Immunis = free, exempt
(18 Nov 1997)
immune adherence The binding of antigen-antibody complexes or cells coated with antibodies or complement to cells bearing the appropriate complement or Fc receptors.
(05 Mar 2000)
immune adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
immune adherence reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound c3 molecules on the c3b receptor sites of the indicator cell.
(12 Dec 1998)
immune adhesion test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
immune adsorption Removal of antibody (agglutinin or precipitin) from antiserum by use of specific antigen; after aggregation has occurred, the antigen-antibody complex is separated either by centrifugation or by filtration, removal of antigen by specific antiserum in a similar manner.
(05 Mar 2000)
immune agglutination Agglutination caused by antibody (agglutinin) that is specific for the suspended microorganism, cell, or for an antigen that has been coated on a particle of suitable size.
(05 Mar 2000)
immune agglutinin 1. An antibody that causes clumping or agglutination of the bacteria or other cells which either stimulated the formation of the agglutinin, or contain immunologically similar, reactive antigen.
Synonym: agglutinating antibody, immune agglutinin.
2. A substance, other than a specific agglutinating antibody, that causes organic particles to agglutinate, commonly qualified, e.g., plant agglutinin.
(05 Mar 2000)
immune complex <immunology> Multimolecular antibody antigen complexes that may be soluble or insoluble depending upon their size and whether or not complement is present.
Immune complexes can be filtered from plasma in the kidney and the deposition of the complexes gives rise to glomerulonephritis probably because of the trapping of neutrophils via their Fc receptors.
(18 Nov 1997)
immune complex disease An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
immune complex diseases Diseases characterised by the presence of immune complexes in body fluids. Hypersensitivity of the Arthus type and serum sickness are examples.
(18 Nov 1997)
immune complex disorder An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
immune complex glomerulonephritis Immune complexes are deposited in the renal glomerulus where they bind complement and initiate an inflammatory process attracting neutrophils and macrophages resulting in an alteration of the basement layer of the kidney. The disease state can lead to ultimate destruction of the glomerulus and renal failure.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • human potentials movement
    Àΰ£ ÀáÀç ´É·Â È¸º¹ ¿îµ¿(ÀÏÁ¾ÀÇ Áý´Ü ¿ä¹ýÀû ¼ö¾ç ¿îµ¿)
  • human power
    ÀÎÀû ÀÚ¿ø
  • human race
    Àηù 
  • human relations
    Àΰ£ °ü°è;´ëÀÎ °ü°è
  • human resource administration
    ÀÎÀû ÀÚ¿ø °ü¸®(Á¾¾÷¿øÀÇ °í¿ë,ÇØ°í,ºÒ¸¸ ó¸® µîÀÇ Àλç°ü¸®)
  • human rights
    (±âº»Àû)ÀαÇ
  • human rights diplomacy
    À뱂 ¿Ü±³(Jimmy Carter¹Ì±¹ Àü´ëÅë·É(1977-81)ÀÇ À뱂 ¿ËÈ£ ÃËÁøÀ» À§ÇÑ ¿Ü±³ ¹æÄ§)
  • human sciences
    Àι® °úÇÐ(ÀηùÇÐ,¾ð¾îÇÐ,»çȸÇÐ,¹®ÇÐ,½É¸®ÇÐ µîÀÇ ÃÑĪ)
  • human torpedo
    Àΰ£ ¾î·Ú(¸ñÇ¥ °¡±îÀ̱îÁö Àΰ£ÀÌ À¯µµÇÔ)
  • fever
    ¿­±¤
  • Japanese river fever
    ¸®ÄÉÂ÷º´
  • Malta fever
    ¸ôŸ¿­(¸ôŸ¼¶ ºÎ±ÙÀÇ À¯Ç༺ °£Çæ¿­)
  • Mediterranean fever
    ÁöÁßÇØ¿­(ÁöÁßÇØ ¿¬¾È Áö¹æ¿¡ ¹ß»ýÇÏ´Â °¢Á¾ ¿­º´,ƯÈ÷ »ç¶÷ÀÇ BRUCRLLOSIS)
  • Rocky Mountain spotted fever
    ·ÎŰ»ê È«¹Ý¿­(Áøµå±â°¡ ¸Å°³ÇÏ´Â º´)
  • blackwater fever
    Èæ¼ö¿­(¾Ç¼º ¸»¶ó¸®¾Æ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á